← Companies
BICYCLE THERAPEUTICS PLC
Data as of Nov 11, 2026
Lobbying
$450,000 in reported federal lobbying spend across 4 quarterly filings, most recently Oct 19, 2026. Amounts are the sums companies and their registrants report on Lobbying Disclosure Act filings; a filing that covers several issues counts its full amount under each.
Spend by issue
- Health Issues +1$300K3 filings
- Pharmacy +1$150K1 filing
Latest filings, Apr 2026 onward
| Filed | Registrant and subject | Amount |
|---|---|---|
| Oct 19, 2026 | LMH STRATEGIC SOLUTIONS for BICYCLE THERAPEUTICS Pharmacy · Health Issues Healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry. General health care coverage and reimbursement for prescription drugs. Drug pricing reform. Food and Drug Admini | $150,000 |
| Jul 5, 2026 | LMH STRATEGIC SOLUTIONS for BICYCLE THERAPEUTICS Health Issues · Pharmacy Healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry. General health care coverage and reimbursement for prescription drugs.
Healthcare-related legislative and regu | $150,000 |
| Apr 20, 2026 | LMH STRATEGIC SOLUTIONS for BICYCLE THERAPEUTICS Health Issues · Pharmacy Healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry. General health care coverage and reimbursement for prescription drugs.
Healthcare-related legislative and regu | $150,000 |
| Apr 17, 2026 | LMH STRATEGIC SOLUTIONS for BICYCLE THERAPEUTICS Health Issues · Pharmacy Healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry. General health care coverage and reimbursement for prescription drugs. Drug pricing reform. Food and Drug Admini | $0 |